Company / EPS (Diluted)
IMMUCELL CORP /DE/ EPS (Diluted) History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.26
FY2025
5-year range
-$0.75 / $0.38
FY2021-FY2025
Trend
+65.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2025 after 3 years of decline, reaching $-0.26.
Based on SEC 10-K filings.
-0.26 in FY2025.
Improved from $-0.32 to $-0.26 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 65.3% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.26 | +65.3% |
| FY2024 | -$0.75 | -134.4% |
| FY2023 | -$0.32 | -366.7% |
| FY2017 | $0.12 | -68.4% |
| FY2016 | $0.38 | +850.0% |
| FY2015 | $0.04 | +33.3% |
| FY2014 | $0.03 | +121.4% |
| FY2013 | -$0.14 | -7.7% |
| FY2012 | -$0.13 | -85.7% |
| FY2011 | -$0.07 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026